These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7395271)

  • 1. Effect of nitroprusside on peritoneal dialysis clearances.
    Finkelstein FO; Yap P; Kliger AS
    Yale J Biol Med; 1980; 53(2):127-32. PubMed ID: 7395271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal clearances with three types of commerically available peritoneal dialysis solutions. Effects of pH adjustment and intraperitoneal nitroprusside.
    Nolph KD; Rubin J; Wiegman DL; Harris PD; Miller FN
    Nephron; 1979; 24(1):34-40. PubMed ID: 40148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intraperitoneal nitroprusside on peritoneal clearances in man with variations of dose, frequency of administration and dwell times.
    Nolph KD; Ghods AJ; Brown PA; Twardowski ZJ
    Nephron; 1979; 24(3):114-20. PubMed ID: 492421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential intraperitoneal administration of nitroprusside in patients maintained on peritoneal dialysis.
    Riambau E; Lloveras J; Aubía J; Masramón J; García C; Orfila MA; Llorach M
    J Dial; 1980; 4(4):203-17. PubMed ID: 7204719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vasodilator and surface active drugs on the efficacy of peritoneal dialysis.
    Kalra OP; Aggarwal HK; Mahajan SK; Seth RK
    J Assoc Physicians India; 1992 Apr; 40(4):233-6. PubMed ID: 1452528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hypertonic dialysate and vasodilators on peritoneal dialysis clearances in the rat.
    Brown EA; Kliger AS; Goffinet J; Finkelstein FO
    Kidney Int; 1978 Apr; 13(4):271-7. PubMed ID: 651126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular and clinical effects of altered peritoneal dialysis solutions.
    Miller FN; Nolph KD; Harris PD; Rubin J; Wiegman DL; Joshua IG; Twardowski ZJ; Ghods AJ
    Kidney Int; 1979 Jun; 15(6):630-9. PubMed ID: 37363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced clearance with intraperitoneal nitroprusside in high flow recirculation peritoneal dialysis.
    Raja RM; Kramer MS; Rosenbaum JL
    Trans Am Soc Artif Intern Organs; 1978; 24():133-5. PubMed ID: 715988
    [No Abstract]   [Full Text] [Related]  

  • 9. Augmented peritoneal mass transport with intraperitoneal nitroprusside.
    Hirszel P; Maher JF; Chamberlin M
    J Dial; 1978; 2(2):131-42. PubMed ID: 681579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of various pharmacological and conventional methods of increasing the effectiveness of peritoneal dialysis. II. Intraperitoneal administration of sodium nitroprusside during intermittent peritoneal dialysis].
    Grzegorzewska A
    Przegl Lek; 1988; 45(6):485-90. PubMed ID: 3252349
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of intraperitoneal vasodilators on peritoneal clearances.
    Nolph KD; Ghods AJ; Van Stone J; Brown PA
    Trans Am Soc Artif Intern Organs; 1976; 22():586-94. PubMed ID: 951875
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of intraperitoneal administration of sodium nitroprusside on the efficacy of peritoneal dialysis.
    Nand N; Mahajan SK; Aggarwal HK; Grover VK; Sharma M
    J Assoc Physicians India; 1995 Mar; 43(3):173-5. PubMed ID: 11256901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal dialysis clearances. A practical approach to the measurement of small- and middle-molecule clearances.
    Brown EA; Kliger AS; Finkelstein FO
    Nephron; 1978; 21(6):310-6. PubMed ID: 714202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis.
    Leypoldt JK; Burkart JM
    Adv Perit Dial; 2002; 18():26-31. PubMed ID: 12402582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intraperitoneal diuretics on solute transport during hypertonic dialysis.
    Maher JF; Hohnadel DC; Shea C; DiSanzo F; Cassetta M
    Clin Nephrol; 1977 Mar; 7(3):96-100. PubMed ID: 870268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of increasing exchange volume and frequency on peritoneal dialysis adequacy.
    Gao H; Lew SQ; Bosch JP
    Clin Nephrol; 1998 Dec; 50(6):375-80. PubMed ID: 9877111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal blood flow and peritoneal transfer parameters during dialysis with administration of drugs.
    Grzegorzewska AE; Antoniewicz K
    Adv Perit Dial; 1995; 11():28-32. PubMed ID: 8534723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved dialysis dose by optimizing intraperitoneal volume prescription thanks to intraperitoneal pressure measurements in children.
    Fischbach M; Terzic J; Dangelser C; Schneider P; Roger ML; Geisert J
    Adv Perit Dial; 1997; 13():271-3. PubMed ID: 9360697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of means to augment peritoneal urea clearances: the synergistic effects of combining high dialysate temperature and high dialysate flow rates with dextrose and nitroprusside.
    De Santo NG; Capodicasa G; Capasso G; Giordano C
    Artif Organs; 1981 Nov; 5(4):409-14. PubMed ID: 7325883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of pharmacologic agents on transperitoneal elimination of low-molecular compounds during peritoneal dialysis].
    Grzegorzewska A
    Pol Arch Med Wewn; 1989; 82(2-3):65-70. PubMed ID: 2638739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.